Transcriptome Sequencing Identifies Abnormal lncRNAs and mRNAs and Reveals Potentially Hub Immune-Related mRNA in Osteoporosis with Vertebral Fracture

References

• El-Gazzar A, Hogler W. Mechanisms of bone fragility: from osteogenesis imperfecta to secondary osteoporosis. Int J Mol Sci. 2021;22(2):625. doi:10.3390/ijms22020625
   PubMed Web of Science ®Google Scholar
• Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364–376. doi:10.1016/S0140-6736(18)32112-3
   PubMed Web of Science ®Google Scholar
• Ettinger MP. Aging bone and osteoporosis: strategies for preventing fractures in the elderly. Arch Intern Med. 2003;163(18):2237–2246. doi:10.1001/archinte.163.18.2237
   PubMedGoogle Scholar
• Watts NB. Postmenopausal osteoporosis: a clinical review. J Womens Health. 2018;27(9):1093–1096. doi:10.1089/jwh.2017.6706
   PubMed Web of Science ®Google Scholar
• Wang L, Yu W, Yin X, et al. Prevalence of osteoporosis and fracture in china: the china osteoporosis prevalence study. JAMA Network Open. 2021;4(8):e2121106. doi:10.1001/jamanetworkopen.2021.21106
   PubMed Web of Science ®Google Scholar
• Zhu J, Gao M, Song Q, et al. Prevalence of osteoporosis in Chinese elderly people: a meta-analysis. Chin Gene Pract. 2022;25(3):346–353.
   Google Scholar
• Toledo SR, Oliveira ID, Okamoto OK, et al. Bone deposition, bone resorption, and osteosarcoma. J Orthop Res. 2010;28(9):1142–1148. doi:10.1002/jor.21120
   PubMed Web of Science ®Google Scholar
• de Souza MP. Osteoporosis diagnosis and treatment. Rev Bras Ortop. 2010;45(3):220–229. doi:10.1590/S0102-36162010000300002
   PubMedGoogle Scholar
• Quesada Gomez JM, Blanch Rubio J, Diaz Curiel M, Diez Perez A. Calcium citrate and vitamin D in the treatment of osteoporosis. Clin Drug Investig. 2011;31(5):285–298. doi:10.1007/BF03256927
   PubMed Web of Science ®Google Scholar
• Foger-Samwald U, Dovjak P, Azizi-Semrad U, Kerschan-Schindl K, Pietschmann P. Osteoporosis: pathophysiology and therapeutic options. EXCLI J. 2020;19:1017–1037. doi:10.17179/excli2020-2591
   PubMed Web of Science ®Google Scholar
• Wong SK, Chin KY, Suhaimi FH, Ahmad F, Ima-Nirwana S. The relationship between metabolic syndrome and osteoporosis: a review. Nutrients. 2016;8(6):347. doi:10.3390/nu8060347
   PubMed Web of Science ®Google Scholar
• Zimmermann EA, Schaible E, Gludovatz B, et al. Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditions. Sci Rep. 2016;6(1):21072. doi:10.1038/srep21072
   PubMedGoogle Scholar
• Srivastava RK, Dar HY, Mishra PK. Immunoporosis: immunology of osteoporosis-role of T Cells. Front Immunol. 2018;9:657. doi:10.3389/fimmu.2018.00657
   PubMed Web of Science ®Google Scholar
• Pietschmann P, Mechtcheriakova D, Meshcheryakova A, Foger-Samwald U, Ellinger I. Immunology of osteoporosis: a mini-review. Gerontology. 2016;62(2):128–137. doi:10.1159/000431091
   PubMed Web of Science ®Google Scholar
• Tsukasaki M, Takayanagi H. Osteoimmunology: evolving concepts in bone-immune interactions in health and disease. Nat Rev Immunol. 2019;19(10):626–642. doi:10.1038/s41577-019-0178-8
   PubMed Web of Science ®Google Scholar
• Zelzer E, Olsen BR. The genetic basis for skeletal diseases. Nature. 2003;423(6937):343–348. doi:10.1038/nature01659
   PubMed Web of Science ®Google Scholar
• Dimai HP. Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment; WHO-criteria, T- and Z-score, and reference databases. Bone. 2017;104:39–43. doi:10.1016/j.bone.2016.12.016
   PubMed Web of Science ®Google Scholar
• Keen MU, Reddivari AKR. Osteoporosis in Females. StatPearls. Treasure Island (FL) Ineligible Companies. Disclosure: Anil Kumar Reddy Reddivari Declares No Relevant Financial Relationships with Ineligible Companies: StatPearls Publishing Copyright © 2023. StatPearls Publishing LLC.; 2023.
   Google Scholar
• Canalis E. MANAGEMENT OF ENDOCRINE DISEASE: novel anabolic treatments for osteoporosis. Eur J Endocrinol. 2018;178(2):R33–R44. doi:10.1530/EJE-17-0920
   PubMed Web of Science ®Google Scholar
• Chen G, Deng C, Li YP. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 2012;8(2):272–288. doi:10.7150/ijbs.2929
   PubMed Web of Science ®Google Scholar
• Ponzetti M, Rucci N. Osteoblast differentiation and signaling: established concepts and emerging topics. Int J Mol Sci. 2021;22(13):6651. doi:10.3390/ijms22136651
   PubMed Web of Science ®Google Scholar
• Chambers TJ. Regulation of the differentiation and function of osteoclasts. J Pathol. 2000;192(1):4–13. doi:10.1002/1096-9896(2000)9999:9999<::AID-PATH645>3.0.CO;2-Q
   PubMed Web of Science ®Google Scholar
• Tsurukai T, Udagawa N, Matsuzaki K, Takahashi N, Suda T. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. J Bone Miner Metab. 2000;18(4):177–184. doi:10.1007/s007740070018
   PubMed Web of Science ®Google Scholar
• Ono T, Hayashi M, Sasaki F, Nakashima T. RANKL biology: bone metabolism, the immune system, and beyond. Inflamm Regen. 2020;40(1):2. doi:10.1186/s41232-019-0111-3
   PubMed Web of Science ®Google Scholar
• Oh SA, Li MO. TGF-beta: guardian of T cell function. J Immunol. 2013;191(8):3973–3979. doi:10.4049/jimmunol.1301843
   PubMed Web of Science ®Google Scholar
• Lee YM, Fujikado N, Manaka H, Yasuda H, Iwakura Y. IL-1 plays an important role in the bone metabolism under physiological conditions. Int Immunol. 2010;22(10):805–816. doi:10.1093/intimm/dxq431
   PubMed Web of Science ®Google Scholar
• Santarlasci V, Cosmi L, Maggi L, Liotta F, Annunziato F. IL-1 and T helper immune responses. Front Immunol. 2013;4:182. doi:10.3389/fimmu.2013.00182
   PubMed Web of Science ®Google Scholar
• Ponzetti M, Rucci N. Updates on osteoimmunology: what’s new on the cross-talk between bone and immune system. Front Endocrinol. 2019;10:236. doi:10.3389/fendo.2019.00236
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhang L, Xiong Q, Gao Y, Ge W, Tang P. Bench-to-bedside strategies for osteoporotic fracture: from osteoimmunology to mechanosensation. Bone Res. 2019;7(1):25. doi:10.1038/s41413-019-0066-7
   PubMedGoogle Scholar
• Kuno K, Matsushima K. The IL-1 receptor signaling pathway. J Leukocyte Biol. 1994;56(5):542–547. doi:10.1002/jlb.56.5.542
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhou Q, Wu Z, Zhu X, Geng T. The effect of IL-1R1 and IL-1RN polymorphisms on osteoporosis predisposition in a Chinese Han population. Int Immunopharmacol. 2020;87:106833. doi:10.1016/j.intimp.2020.106833
   PubMed Web of Science ®Google Scholar
• Colotta F, Dower SK, Sims JE, Mantovani A. The type II ‘decoy’ receptor: a novel regulatory pathway for interleukin 1. Immunol Today. 1994;15(12):562–566. doi:10.1016/0167-5699(94)90217-8
   PubMedGoogle Scholar
• Braun T, Zwerina J. Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Res Ther. 2011;13(4):235. doi:10.1186/ar3380
   PubMed Web of Science ®Google Scholar
• Rong K, Liang Z, Xiang W, Wang Z, Wen F, Lu L. IL1R2 polymorphisms and their interaction are associated with osteoporosis susceptibility in the Chinese Han population. Int J Immunogenet. 2021;48(6):510–525. doi:10.1111/iji.12547
   PubMed Web of Science ®Google Scholar
• Tang M, Tian L, Luo G, Yu X. Interferon-gamma-mediated osteoimmunology. Front Immunol. 2018;9:1508. doi:10.3389/fimmu.2018.01508
   PubMed Web of Science ®Google Scholar
• Simsa-Maziel S, Zaretsky J, Reich A, Koren Y, Shahar R, Monsonego-Ornan E. IL-1RI participates in normal growth plate development and bone modeling. Am J Physiol Endocrinol Metab. 2013;305(1):E15–E21. doi:10.1152/ajpendo.00335.2012
   PubMed Web of Science ®Google Scholar
• Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol. 2002;20(5 Suppl 27):S1–13.
   PubMed Web of Science ®Google Scholar
• Mansoori MN, Shukla P, Kakaji M, et al. IL-18BP is decreased in osteoporotic women: prevents Inflammasome mediated IL-18 activation and reduces Th17 differentiation. Sci Rep. 2016;6(1):33680. doi:10.1038/srep33680
   PubMed Web of Science ®Google Scholar
• Palomo J, Dietrich D, Martin P, Palmer G, Gabay C. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases. Cytokine. 2015;76(1):25–37. doi:10.1016/j.cyto.2015.06.017
   PubMed Web of Science ®Google Scholar
• De Martinis M, Ginaldi L, Sirufo MM, et al. Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: a Literature Review. Medicina. 2020;56(3):138. doi:10.3390/medicina56030138
   PubMedGoogle Scholar
• Weng S, Zhang D-E. The GM-CSF Receptor Alpha Chain (CSF2RA) Functions As a Novel Ligand-Independent Tumor Suppressor in t (8;21) AML. Blood. 2015;126(23):3589.
   Web of Science ®Google Scholar
• Anam K, Davis TA. Comparative analysis of gene transcripts for cell signaling receptors in bone marrow-derived hematopoietic stem/progenitor cell and mesenchymal stromal cell populations. Stem Cell Res Ther. 2013;4(5):112. doi:10.1186/scrt323
   PubMedGoogle Scholar
• Chen F. Expression and clinical value analysis of CSF2RA in malignant tumor based on database. J Biosci Med. 2021;9(04):149–157. doi:10.4236/jbm.2021.94013
   Google Scholar
• Kalajzic I, Staal A, Yang WP, et al. Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem. 2005;280(26):24618–24626. doi:10.1074/jbc.M413834200
   PubMed Web of Science ®Google Scholar
• Li C, Li G, Liu M, Zhou T, Zhou H. Paracrine effect of inflammatory cytokine-activated bone marrow mesenchymal stem cells and its role in osteoblast function. J Biosci Bioeng. 2016;121(2):213–219. doi:10.1016/j.jbiosc.2015.05.017
   PubMed Web of Science ®Google Scholar
• Yang Z, Ni J, Kuang L, Gao Y, Tao S. Identification of genes and pathways associated with subchondral bone in osteoarthritis via bioinformatic analysis. Medicine. 2020;99:37.
   Web of Science ®Google Scholar
• Xie W, Lorenz S, Dolder S, Hofstetter W. Extracellular iron is a modulator of the differentiation of osteoclast lineage cells. Calcif Tissue Int. 2016;98(3):275–283. doi:10.1007/s00223-015-0087-1
   PubMed Web of Science ®Google Scholar
• Luo H, Gu R, Ouyang H, et al. Cadmium exposure induces osteoporosis through cellular senescence, associated with activation of NF-kappaB pathway and mitochondrial dysfunction. Environ Pollut. 2021;290:118043. doi:10.1016/j.envpol.2021.118043
   PubMed Web of Science ®Google Scholar
• Rosendahl S, Sulniute R, Eklund M, et al. CCR3 deficiency is associated with increased osteoclast activity and reduced cortical bone volume in adult male mice. J Biol Chem. 2021;296:100177. doi:10.1074/jbc.RA120.015571
   PubMed Web of Science ®Google Scholar
• Guerard A, Laurent V, Fromont G, et al. The chemokine receptor CCR3 is potentially involved in the homing of prostate cancer cells to bone: implication of bone-marrow adipocytes. Int J Mol Sci. 2021;22(4):1994. doi:10.3390/ijms22041994
   PubMed Web of Science ®Google Scholar